Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
77.32
+1.17 (1.54%)
At close: May 18, 2026, 4:00 PM EDT
77.34
+0.02 (0.02%)
After-hours: May 18, 2026, 7:59 PM EDT
Medtronic Revenue
Medtronic had revenue of $9.02B in the quarter ending January 23, 2026, with 8.74% growth. This brings the company's revenue in the last twelve months to $35.48B, up 6.88% year-over-year. In the fiscal year ending April 25, 2025, Medtronic had annual revenue of $33.54B with 3.62% growth.
Revenue (ttm)
$35.48B
Revenue Growth
+6.88%
P/S Ratio
2.80
Revenue / Employee
$373,516
Employees
95,000
Market Cap
99.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
| Apr 26, 2019 | 30.56B | 604.00M | 2.02% |
| Apr 27, 2018 | 29.95B | 243.00M | 0.82% |
| Apr 28, 2017 | 29.71B | 877.00M | 3.04% |
| Apr 29, 2016 | 28.83B | 8.57B | 42.31% |
| Apr 24, 2015 | 20.26B | 3.26B | 19.15% |
| Apr 25, 2014 | 17.01B | 415.00M | 2.50% |
| Apr 26, 2013 | 16.59B | 406.00M | 2.51% |
| Apr 27, 2012 | 16.18B | 676.00M | 4.36% |
| Apr 29, 2011 | 15.51B | 116.00M | 0.75% |
| Apr 30, 2010 | 15.39B | 793.00M | 5.43% |
| Apr 24, 2009 | 14.60B | 1.08B | 8.02% |
| Apr 25, 2008 | 13.52B | 1.22B | 9.89% |
| Apr 27, 2007 | 12.30B | 1.01B | 8.92% |
| Apr 28, 2006 | 11.29B | 1.24B | 12.30% |
| Apr 29, 2005 | 10.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 45.13B |
| Stryker | 25.27B |
| GE HealthCare Technologies | 20.98B |
| Boston Scientific | 20.61B |
| Koninklijke Philips | 20.34B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
MDT News
- 3 days ago - Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks. - Barrons
- 12 days ago - Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement - GlobeNewsWire
- 18 days ago - FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy - GlobeNewsWire
- 20 days ago - Medtronic receives CE mark for Stealth AXiS surgical system - TheFly
- 20 days ago - Medtronic announces CE Mark for Stealth AXiS™ surgical system - PRNewsWire
- 21 days ago - Medtronic says cyberattack on IT network has not disrupted operations - Reuters
- 22 days ago - Medtronic announces milestones for Sphere-9, Sphere 360 catheters - TheFly
- 22 days ago - Medtronic announces FDA granted Breakthrough Device Designations to Sphere-9 - TheFly